Polyethylenimine-complexed Plasmid Particles Targeting Focal Adhesion Kinase Function as Melanoma Tumor Therapeutics
Open Access
- 1 March 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (3) , 515-523
- https://doi.org/10.1038/sj.mt.6300072
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30028012, 30330530, 30425009)
- Ministry of Education of the People's Republic of China (SRFDP 20030284040, TRAPOY 199028418)
This publication has 31 references indexed in Scilit:
- RETRACTED: Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cellsJournal of Controlled Release, 2005
- Focal Adhesion Kinase Promotes the Aggressive Melanoma PhenotypeCancer Research, 2005
- RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivoGene Therapy, 2004
- Elevated focal adhesion kinase expression facilitates oral tumor cell invasionCancer, 2002
- Lipoplex-induced hemagglutination: potential involvement in intravenous gene deliveryGene Therapy, 2002
- Side‐effects of a systemic injection of linear polyethylenimine–DNA complexesThe Journal of Gene Medicine, 2001
- Focal Adhesion Kinase Facilitates Platelet-derived Growth Factor-BB-stimulated ERK2 Activation Required for Chemotaxis Migration of Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2000
- Matrix metalloproteinasesEuropean Journal Of Cancer, 2000
- Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinomaInternational Journal of Cancer, 1996
- Flow Cytometric Determination of Degraded Deoxyribonucleic Acid in Granulosa Cells to Identify Atretic Follicles during Preovulatory Maturation in the Pig1Biology of Reproduction, 1994